Palleos Healthcare has a distinguished history of advancing medical innovations, leveraging its extensive experience and network to accelerate the development of new therapies. By integrating academic ...

Scorpius Holdings partners with biotech firm to expand U.S.-based biomanufacturing capabilities for innovative biologics ...

Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines the precision of monoclonal antibodies with the potency of ...

Increasingly advanced therapies are making their way into the pharmaceutical mainstream – but so too are an increasingly ...

Despite global clinical trials increasing by 38% over the past decade, the European Economic Area’s (EEA) global share of trials has halved over the same period. A new report by IQVIA for EFPIA and ...

DelveInsight's 'JAK Inhibitors Pipeline Insight 2024' report provides comprehensive global coverage of pipeline JAK ...

The FDA mandate to increase diversity in clinical trials fails to address critical issues in treatment for Black women, according to experts.

The positive results from the double-blind period of the RISE UP Phase 2 study, which were presented at the 65 th American Society of Hematology (ASH) Annual Meeting & Exposition in December 2023, ...

The global nanomedicine market is growing rapidly, driven by advances in nanotechnology-based drug delivery and personalized ...

NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of ...

Discover the applications of Ttau PFFs and alpha-synuclein PFFs in advancing neurodegenerative disease research.

Danaher's acquisition-focused strategy makes financial flexibility and capital market access important. In recent years, the company has issued debt to make significant acquisitions, such as Beckman ...